chrisvoncsefalvay/vaers-outcomes huggingface dataset:
H1N1 was given at a school based vaccination clinic on XX/XX/09 to a student who was under 10 years old. Due to communication error it was never realized that the student had been given the 1st H1N1 at his health care provider on XX/XX/09. The epidemiologist at the XXXX was notified and stated that the second dose did not count and unless there were adverse effects there was no reason to do a VAERS (Vaccine Adverse Event Reporting System). I spoke with the parent and there was no adverse reaction, she had also notified the students health care provider of the extra dose. The plan is to administer the next dose on XX/XX/09, which will be counted as the students second dose. Parent made aware of this, XXXX referred me to this web site to complete this error. No adverse reaction. The plan is to administer the next dose on XX/XX/09, which will be counted as the students second dose.
This spontaneous report was received from a medical assistant via office  manager and refers to a patient of unknown age and gender. On 26-AUG-2014 the patient was vaccinated with LQIUID PEDVAXHIB (lot # K000331, expiry 23-OCT-2016, dose, dose # and route unspecified) that was exposed to temperatures outside of the proper storage range on unspecified dates. No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
When the patient was a baby he had a high-pitched cry and high fever for several days. The patient was at home and recovered. The patient is now a teenage and he has huge gaps between his teeth that need corrective work. The dentist said this was caused by a high fever.
Palms itchy, hives/welts (looked like mosquito bites) that appeared and disappeared, larger welt around site; swollen, red, hot, bruising-continued for days Co-workers (RNs) looked at Treating with Hydrocortisone cream and ice Will follow up with urgent care tomorrow if no improvement
Fever to 100.1 chills body aches headache joint pain nausea  Two doses acetaminophen 14 and 21 hours after vaccination Motrin 400 mg 27 hours after vaccination  Still febrile at 99.6 36 hours after vaccination
Fever up to 103 (R) for 2-3 days. He has also had cold symptoms (runny nose, congestion and cough). Treated only with Tylenol and ibuprofen.
Patient is non-verbal. Developed increased anxiety and change in behavior, then started to limp. No trauma or injury to the area. Went to the ED for further evaluation, was sent home with supportive care. Noted to have elevated CK, elevated WBC, elevated platelets on labs. No other viral or sick symptoms at time of presentation.
PAIN IN LEFT UPPER ARM PERSISTING X2 WEEKS. NO REDNESS, SWELLING, WARMTH, NUMBNESS OR TINGLING. SHE IS TAKING IBUPROFEN WITH LIMITED RELIEF.
Adverse effects began after second dose and included the following: Sore Arm after injection (normal pain at point of injection) + COVID Symptoms for two days (Also Normal and expected) Extreme Vertigo (Second Day) Ive never had vertigo before Arm Pain continued to and progressively worsened Shoulder Pain began and progressively worsened To Date (May 17, 2021) Vertigo improved but is still present Arm/Shoulder pain continues to worse or fails to improve
18NOV91 had general malaise achiness low grade temp 99.8 flu shot in 13NOV91 seen @ hosp in ER given symmetrall on 19JAN91; no rxn reported x 5 days;
Several red raised spots on both legs on knee and below. No difficulty breathing, swelling, or itching noted.
2nd dose more than two years from the first; This case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too long in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 28th August 2018).   On 2nd November 2020, the patient received the 2nd dose of Shingrix. On 2nd November 2020, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follows: The patient self reported the case. The patient called to ask if there was any information on the efficacy of taking Shingrix later than the recommended dosing schedule. She stated that, she took the second dose about a year and a half later, later than the recommended interval, which led to lengthening of vaccination schedule, after she spoke with her healthcare professional who recommended her took the second dose as soon as possible.  Call center representative provided information per content on Food drug administration and CDC recommendations and referred to healthcare professional.  She asked if there was a possibility of getting a booster, call center representative told her per content there was no approved booster for Shingrix available.  The patient verbalized understanding. The reporter consented to follow up.
Upset Stomach - Resolved after 8 1/2  hours Body Aches - Resolved after 24 hours Chills - Resolved after 24 hours Fatigue - Resolved after 48 hours
Metallic taste and pulsating of the base of my tongue that is in the back of my throat.
Sore throat; Fatigue; Weakness; Nausea; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 03Apr2021 at 10:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to tree nuts. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication taken within two weeks of vaccination was not reported. On 08Apr2021 at 16:00, the patient experienced sore throat, fatigue, weakness, nausea and dizziness. Since the vaccination, the patient had not been tested for COVID-19.  The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sore throat, fatigue, weakness, nausea and dizziness was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Patient given Menacta vaccine subcutaneously. Returned to the office within 24 hours with 1.5cm x 1cm reddend, tender area. No fever, edema or streaking. Skin intact.
Moderna vaccine administration to a 16 year old; A spontaneous report was received from a nurse concerning a 16-year-old, female who received Moderna's COVID-19 vaccine (mRNA-1273).  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 19 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (Batch number: 007M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 19 Feb 2021, it was reported that the Moderna COVID-19 vaccine was administered to 16-year-old. No adverse events were reported.  No treatment information was provided.   Action taken with mRNA-1273 in response to the event was not reported.   On 19 Feb 2021, the outcome of the event, product administered to patient of inappropriate age, was considered recovered/resolved.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age (16 year old female) for mRNA-1273 (lot number 007M20A) with no associated AEs reported.
t103.1, rash started 16NOV92 on lt thigh rash filled w/white pus & spread all over body; went to ER 16NOV & 21NOV dx bacterial infection? placed on ATB;
Acute onset Dense Bell's Palsy R side of leg less than 24 hours after flu shot.
positive for covid19; positive for covid19; got or felt sick; This is a spontaneous report from a contactable physician reported for self and consumer. This 51-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on Dec2020 at single dose for covid-19 immunisation. As soon as patient got vaccine she got or felt sick  in Dec2020 and had the test and finds out she was positive, so she stays home two weeks and doesn't have no symptom at all and wants to know when has to take a test. The day after the patient developed symptoms thought it was the vaccine, but the symptoms continued for 2-3 days, the 3rd day the patient got herself tested. The patient was positive for covid19 at the time had the shot/ as soon as she got vaccinated she became positive. The patient hasn't had any symptoms for the past 2 weeks. The patient was scheduled to get retested. The patient was scheduled for 2nd dose of vaccine. The patient asked if there are any risks since developed covid the day after getting the vaccine. What if miss today. The patient wanted to know time after having no symptoms past two weeks, when she has to take a test. Outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Test positive for covid19 found as soon as following the vaccination, no adequate effect of the suspect vaccine thus could be reasonably achieved to protect from the targeted infection/disease due to the very short time lag.
low grade fever and chills. patient was much better after 36 hours from 2nd dose,
her legs just ache; someone who had recently had the vaccine on 15Sep2021 and developed a rash; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) from medical information team.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 15Sep2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RASH (non-serious) with onset 2021, outcome "unknown", described as "someone who had recently had the vaccine on 15Sep2021 and developed a rash"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "her legs just ache".  Additional information: There are only AE for someone but not for caller herself, hence seems the gender female is not for the real patient someone. As per call recording, Caller mentioned that I broke out in a rash from them. By them, Caller was referring to a person that received a COVID Vaccine.   Follow-up attempts completed. No further information is expected.
Child became sick within a weeks time, with flu like symptoms, tired, cranky, irritable, stomach pains, severe loss of appetite and not drinking enough, up through the night for weeks, extreme yeast infection on his bottom that lasted for 2 months culminating with a trip to the ER (at 13-14 months old) with an unknown Bacterial infection and yeast overgrowth, plus dehydration. Child lost all 10 words he knew after two weeks from receiving the MMR shot. He became completely mute. Began hand flapping, moaning, no eye contact, did not respond to his name, or parents, or anyone. There was no treatment for the following 8 months because, doctor kept insisting there was nothing wrong with our child. Finally after months of the doctors not addressing our concerns about our child, we switched doctors. By 23 months old he was diagnosed with Autism. Since then he has been receivng speech therapy, occupational therapy,and ABA therapy. Follow-up: Autism, encephalopathy, hypotonia, speech and language delay, sensory integration disorder, ADHD, and behavioral deficits, stimulatory behaviors. He continues to need intensive speech, OT, and ABA therapy.
G45.9 TRANSIENT CEREBRAL ISCHEMIA 3/24/2023 FUNCTIONAL NEUROLOGICAL SYMPTOM DISORDER W MIXED SYMPTOMS
Herpes zoster; Information has been received regarding a case in litigation from a lawyer, a female patient of unknown age, and her husband. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the zoster vaccine live (ZOSTAVAX) by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 12-SEP-2012, at age 63, the patient was administered the zoster vaccine live (ZOSTAVAX) by a healthcare provider at a physician's office (lot number, dosage and route of administration not provided). On an unknown date, the patient was treated by a physician for the following injury resulting from the patient's zoster vaccine live (ZOSTAVAX) use: Herpes zoster. The patient claimed damages as a result of: injury to themselves, loss of consortium, loss of services, and economic losses. The outcome of the herpes zoster is unknown.  Additional information has been requested.
She experienced pain in the legs and knee; She experienced pain in the legs and knee; If she can take Ibuprofen or Tylenol; This is a spontaneous report from a contactable consumer (patient) reported for herself. This is a report received from a Pfizer sponsored program. A female patient of an unspecified age received (BNT162B2, Formulation: Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on 02Mar2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical and concomitant medications were not reported. The patient reported that first dose taken on 02Mar2021 and on 06Mar2021, she experienced pain in the legs and knees. She wanted to know if that was a side effect from the vaccine, and if she can take Ibuprofen or Tylenol, second dose will be on 23Mar2021. The patient experienced she experienced pain in the legs and knee, she experienced pain in the legs and knee on 06Mar2021 and if she can take Ibuprofen or Tylenol on Mar2021. The clinical outcome of the events was unknown.  Follow-up attempts completed. No further information expected.
No adverse reaction. Noted 1 component of Trihibit was expired (DTap).
When he received his second dose of Moderna he reported that after his first dose he had felt some pain immediately but then 2 days later he experienced a "twingy/numbness-like feeling" down his arm that comes and goes through out the day. Nothing makes it better or worse.He states he has never had any issues before with shots. Phone call to him5/5/21- he is still experiencing the same thing.  It does not affect his work he says, it's just something he has learned to ignore.
a month later the itching started; This is a spontaneous report from a contactable consumer (patient). A female patient of unknown age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, lot number: EP7534, Expiry date: unknown), via unspecified route on 05Feb2021 as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medication was not reported. On 05Feb2021, the patient received the last dose of Covid-19 vaccine. On 05Mar2021, the patient started experiencing itching. The patient asked if someone reported severe itching after receiving the vaccine. The patient think that symptoms because of lymphoma and thinks that it may be causing them. The outcome of the events was unknown.  No follow-up attempts were completed; information about lot/batch number cannot be obtained.
M-M-R II was given via intramuscular route; No additional adverse event; This spontaneous report as received from a registered pharmacist, and refers to a patient of unknown age and gender. The information about patient's concurrent condition, medical and drug history and concomitant medications was not provided.  On 20-DEC-2021, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II), one dose/once, lot # T013728, expiration date: 21-APR-2022 intramuscularly (Incorrect route of product administration) as prophylaxis (anatomical location were not provided).  No additional adverse events were reported.
Pt has abt 2" size rash on injection site. On 6/11 and 6/12 (left arm).
Migraine headache; Face went numb; Hands turned red; Heart raced; This is a spontaneous report from a contactable consumer. A 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6199), via an unspecified route of administration, administered in left arm on 05Mar2021 12:15 (at the age of 45 years old) as 1st dose, single for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously took azithromycin (ZITHROMAX) and, cefdinir (OMNICEF) and experienced allergies. The patient has no COVID history prior vaccination. The patient was not COVID tested post vaccination. On 05Mar2021 12:45, the patient's face went numb, hands turned red, heart raced, and had migraine headache progressively getting worse for four (4) days. The patient had to go to hospital for headache on 4th day, she has got treatment and her headache went away. It was also reported that she woke up on 5th day and her headache came back. The only persistent symptom is headache. The adverse events resulted in Emergency room/department or urgent care visit. The event migraine headache was treated with cocktail IV and CT scan was referred. The patient has not recovered from the event migraine headache, and was recovering from other events.   No follow-up attempts are possible. No further information is expected.
Pt reports " Shortly after receiving vaccine, maybe next week of first shot started have general body aches all the time that didn't have previously, also had long and heavy periods which is uncommon for her."
This spontaneous report was received from a Registered Nurse, concerning an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical history provided. Between 01-FEB-2018 and 20-APR-2018, the patients were inadvertently vaccinated with improperly stored VARIVAX, 0.5 ml subcutaneously, lot # N029631, N022983 and N031001 (anatomical location and expiration dates not provided) and PROQUAD, lot # 022954, N001490, N025923, N035172 and lot # reported as N031294 (route of administration, anatomical location and expiration dates were not provided). Both vaccines were administered for prophylaxis and reconstituted with properly stored sterile diluent (MERCK). The administered doses of the vaccines experienced an unknown temperature excursion during an unknown time frame, and was recorded by a data logger. The vaccines had not had any previous temperature excursions. There was no adverse effect reported. No product quality complaint was involved. Lot Number N031294 is an invalid lot for Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live. This is a non-valid report due to lack of patient identifiers.
Patient is a 11 year old that received a Bivalent 12 and up.
Headache, NauseaVomiting, broken blood vessel in eye, sore arm Narrative: Headache started on night after vaccination, then on 1/13 woke up with a broken blood vessel in eye. Had a few bouts of nausea, did not vomit. Took Tylenol OTC. Today still has a broken blood vessel in eye, does not hurt and vision is clear, lingering dull headache.
My initial was the next morning after receiving the vaccine around two AM was similar to the Pfizer vaccine reactions general malaise and an elevated heart rate it was @ 85BPM. My resting heart heart due to the fact I am a runner is at 62BPM. I had a temperature of 100.2 degrees, normal is @ 97 degrees for me. By Sunday morning I was feeling better but then I began to have headaches on 09MAY2023 through 10MAY2023 I missed two days of work. I was sick to my stomach and nauseated.
Tinnitus in left ear, which had previously been manageable, increased significantly about three hours post shot. Issue still persists 14 hours later.
Aseptic meningitis with 700 mononuclear cells 2 weeks following Menactra.  06/04/2007 MR received for hospital admit for 5/7-9/2007 for c/o of malaise, fever, vomiting,headaches, stiff neck, and lower leg pain. PE significant for nuchal rigidity.  Temp of 100.9'F. otherwise WNL. DX: Meningitis.
Became dizzy and clammy after vaccine while in observation area.  Stated he felt like he was going to faint
This case was reported by a healthcare professional and described the occurrence of stopped breathing in a 49-year-old male subject who was vaccinated with FLULAVAL (GlaxoSmithKline). On 21 September 2009 between 08:15 and 08:30, the subject received a dose of FLULAVAL (unknown). On 21 September 2009, within 15 to 30 minutes of vaccination with FLULAVAL, the subject experienced stopped breathing, passed out, seizure and nonspecific reaction. The healthcare professional reported a subject experienced a "reaction" in the office after receiving FLULAVAL. The subject passed out, had a seizure and stopped breathing. The rescue squad was called and he was taken to the emergency room. It is unknown what type of treatment he received, although all events resolved that day. The healthcare professional considered the events were life threatening. On 21 September 2009, the events were resolved. The healthcare professional considered the events were possibly related to vaccination with FLULAVAL.
Pt had severe hypoxia episode about 20 hrs p/DTP; resus./CPR, had injury to brain due to hypoxia, & blindness, was hospitalized;
Pain right knee 1 week.  Takes Tylenol 325 mg 2 tablets twice a day.  Weakness and tiredness 1 week.
Pt presented with new onset seizures Pt transported to hospital by EMS admitted for full evaluation. Inpatient course uneventful with normal video EEG and CSF studies. Pt diagnosed with atypical febrile seizure. Pt also was diagnosed with RSV in hospital. Pt was treated with acyclovir and ceftriaxone until cultures negative.
The HCP administered an expired Moderna Vaccine to the patient; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The HCP administered an expired Moderna Vaccine to the patient) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 049E21A and 026C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (The HCP administered an expired Moderna Vaccine to the patient). On 14-Oct-2021, EXPIRED PRODUCT ADMINISTERED (The HCP administered an expired Moderna Vaccine to the patient) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant and treatment medication was not provided.
Pt called stating he had a reaction to the pneumococcal vaccine with rash and redness states he took Benadryl and is doing much better.
The day after the shot I had a 101 fever, chills, sweats, tiredness, body ache and headache along with arm pain. The following day I had a migraine & a rash formed all over my body
Chills, arthralgias, swelling at injection site, fever to 100.4 (F) w/chills, loose stools and nausea and headache. Took 2 doses of Ibuprofen + 1 dose of Tylenol for above symptoms. Sx began approximately 24 hours after injection - patient missed day of work (3/16/07) and symptoms treated 24 hours.
States that area where shot was given hurt from the time she got the shot. No time given as to symptoms beginning. Stated that area swelled up, about 1 inch area. "Hot, kind of hard". She initially called PH to report her reaction late afternoon of 11/29/2006, two days after shot given.
Moderna 2/9/21, 3/9/21. Positive on 8/11/22
Nausea and diarrhea started 3 hours after administration. Sever diarrhea lasted for a few hours. Had chills all night and then felt very lethargic and drained the next day. Felt somewhat better on the day after that and then significantly better with just a sore arm the day after that.